The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption—a nation-wide perspective in Sweden-Reference-Cited by-同舟云学术

The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption—a nation-wide perspective in Sweden

Published:2003-06 Issue:5 Volume:9 Page:271-276
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Askmark Håkan,Antonov Karolina,Aquilonius Sten-Magnus

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference23 articles.

1. Success and problems of long term levodopa theray in parkinson's disease;Marsden;Lancet,1977

2. Oxidation reactions in parkinson's disease;Olanow;Neurology,1990

3. Is levodopa toxic?;Fahn;Neurology,1996

4. Levodopa in the treatment of parkinson's disease: a consensus meeting;Agid;Mov Disord,1999

5. A rationale for dopamine agonists as primary therapy in parkinson's disease;Olanow;Can J Neurol Sci,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns and Determinants of Prescribing for Parkinson’s Disease: A Systematic Literature Review;Parkinson's Disease;2019-11-03

2. Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010;PLoS ONE;2014-06-06

3. Initiatives to improve prescribing efficiency for drugs to treat Parkinson’s disease in Croatia: influence and future directions;Expert Review of Pharmacoeconomics & Outcomes Research;2012-06

4. Impact of recommendations on the initial therapy of Parkinson’s disease: A population-based study in France;Parkinsonism & Related Disorders;2011-08

5. Ongoing challenges to finding people with Parkinson’s disease for epidemiological studies: A comparison of population-level case ascertainment methods;Parkinsonism & Related Disorders;2011-07